$BG Medicine (BGMD)$ DEF 14A - Other definitive proxy statements Filed: 2016-06-23 AccNo: 0001193125-16-629550 Size: 467 KB 网页链接
$BG Medicine (BGMD)$ 15-12B - Securities registration termination [Section 12(b)] Filed: 2016-05-05 AccNo: 0001193125-16-579902 Size: 10 KB 网页链接
$BG Medicine (BGMD)$ 内部交易: 2016-04-14,SVP & Chief Scientific Officer,Adourian Aram S. ,期权,12000普通股, $0.90
$BG Medicine (BGMD)$ CT ORDER - Confidential treatment order Filed: 2016-05-04 AccNo: 9999999997-16-022645 Size: 10 KB 网页链接
$BG Medicine (BGMD)$ 10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2016-04-29 AccNo: 0001193125-16-569329 Size: 377 KB 网页链接
$BG Medicine (BGMD)$ 美东时间 2016-07-06 10:00 BG Medicine Inc Annual Shareholders Meeting (Estimated) 网页链接
$BG Medicine (BGMD)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2016-04-04 AccNo: 0001193125-16-529513 Size: 6 MB 网页链接
$BG Medicine (BGMD)$ EFFECT - Notice of Effectiveness Filed: 2016-03-31 AccNo: 9999999995-16-004089 Size: 1 KB 网页链接
$BG Medicine (BGMD)$ NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 Filed: 2016-03-31 AccNo: 0001193125-16-526033 Size: 23 KB 网页链接
$BG Medicine (BGMD)$ 8-K - Current report Filed: 2016-03-31 AccNo: 0001193125-16-526005 Size: 16 KBItem 2.02: Results of Operations and Financial ConditionItem 8.01: Other Events 网页链接